0001209191-18-027898.txt : 20180503
0001209191-18-027898.hdr.sgml : 20180503
20180503194216
ACCESSION NUMBER: 0001209191-18-027898
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180501
FILED AS OF DATE: 20180503
DATE AS OF CHANGE: 20180503
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: POPS RICHARD F
CENTRAL INDEX KEY: 0001126490
STATE OF INCORPORATION: DE
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-22705
FILM NUMBER: 18805651
MAIL ADDRESS:
STREET 1: 10555 SCIENCE CENTER DR
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NEUROCRINE BIOSCIENCES INC
CENTRAL INDEX KEY: 0000914475
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 330525145
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12780 EL CAMINO REAL
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: (858) 617-7600
MAIL ADDRESS:
STREET 1: 12780 EL CAMINO REAL
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-05-01
0
0000914475
NEUROCRINE BIOSCIENCES INC
NBIX
0001126490
POPS RICHARD F
12780 EL CAMINO REAL
SAN DIEGO
CA
92130
1
0
0
0
Common Stock
2018-05-01
4
M
0
15000
7.05
A
44512
D
Common Stock
2018-05-01
4
F
0
1253
84.39
D
43259
D
Non-Qualified Stock Option
7.05
2018-05-01
4
M
0
15000
7.05
A
2011-06-25
2018-05-25
Common Stock
15000
0
D
The share issuance reported on Table I reflects shares issued upon the exercise of options granted on May 25, 2011, which, if unexercised would have expired on May 25, 2018. The option exercises are reported on Table II. These option exercises were pursuant to a net issuance arrangement effected under the Issuer's 2003 Equity Incentive Plan, as amended. The number of shares issued pursuant to the net issuance arrangement was calculated as follows: the option exercise price ($7.05) was subtracted from the May 01, 2018 market close price ($84.39), and this net amount ($77.34) was then multiplied by the number of options (15,000), with the resulting amount then divided by the market close price to result in a net issuance of 13,747 shares to the optionee. The 1,253 shares underlying the remaining portion of the options are not available for re-issuance, and no shares were sold into the market as a part of the exercise in connection with a net issuance program.
/s/ Darin Lippoldt, Attorney-in-Fact
2018-05-03